Welcome to the Newsroom
18 May 2017
Data from Prima BioMed AIPAC Clinical Trial to be Presented at 2017 ASCO Conference
SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima” or the
“Company”) today announced that an abstract and poster have been accepted for presentation
at the American Society of Clinical Oncology (ASCO) 53rd annual meeting to be held in Chicago,
Illinois, 2-6 June 2017.
Article as pdf